SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics GAAP EPS of -$0.63, revenue of $0.5M [Seeking Alpha]
Silence Therapeutics (SLN) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
Silence Therapeutics (SLN) had its "outperform" rating reaffirmed by William Blair.
With 35% ownership, Silence Therapeutics plc (NASDAQ:SLN) insiders have a lot at stake [Yahoo! Finance]
Form S-8 Silence Therapeutics
Form 10-K Silence Therapeutics For: Dec 31
Form 8-K Silence Therapeutics For: Mar 05
Form 4 Silence Therapeutics For: Aug 03 Filed by: Griffiths Richard Ian
Form SCHEDULE 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.